Oncology: International Journal of Cancer Research and Treatment
Published online: July 27, 2017
Utter K., Goldman C., Weiss S.A., Shapiro R.L., Berman R.S., Wilson M.A., Pavlick A.C., Osman I.
Background: Metastatic melanoma of unknown primary (MUP) is uncommon, biologically ill defined, and clinically understudied. MUP outcomes are seldom reported in clinical trials. In this study, we analyze responses of MUP patients treated with systemic therapy in an attempt to inform treatment guidelines for this unique population.